Chinese english Germany Japanese Korea

CF 1743

CF 1743 Struktur
319425-66-6
CAS-Nr.
319425-66-6
Englisch Name:
CF 1743
Synonyma:
CF 1743;Furo[2,3-d]pyrimidin-2(3H)-one, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)-
CBNumber:
CB63599835
Summenformel:
C22H26N2O5
Molgewicht:
398.46
MOL-Datei:
319425-66-6.mol
Request For Quotation

CF 1743 Eigenschaften

Schmelzpunkt:
>230°C (dec.)
Siedepunkt:
624.2±65.0 °C(Predicted)
Dichte
1.36±0.1 g/cm3(Predicted)
storage temp. 
Amber Vial, -20°C Freezer, Under inert atmosphere
Löslichkeit
DMSO (Slightly), Methanol (Slightly, Heated)
pka
13.92±0.60(Predicted)
Aggregatzustand
Solid
Farbe
White to Off-White
Stabilität:
Light Sensitive

Sicherheit

CF 1743 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

CF 1743 is an orally available nucleoside analogue drug with antiviral activity. It is a potent and selective inhibitor of varicella zoster virus.

CF 1743 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

CF 1743 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 18)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354; +17819995354
 marketing@targetmol.com United States 32435 58
NewCan Biotech Limited 		+86-0571-86912261 +8613735419629
 sales@newcanbio.com China 9985 58
Energy Chemical 021-58432009 400-005-6266
 marketing@energy-chemical.com China 44918 58
TargetMol Chemicals Inc. 4008200310
 marketing@tsbiochem.com China 24961 58
Suzhou Meishi Biotechnology Co., Ltd. 1173954148q
 meishipharma@126.com China 20033 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627
 customer_service@efebio.com China 11973 58
Sangon Biotech (Shanghai) Co.,Ltd. 400-821-026
Sales@sangon.com China 6710 58
Biosynth Biological Technology (Suzhou) Co Ltd 51288865780
 sales@biosynth.com China 6051 58
  • CF 1743
  • Furo[2,3-d]pyrimidin-2(3H)-one, 3-(2-deoxy-β-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)-
  • 319425-66-6
Copyright 2019 © ChemicalBook. All rights reserved